Safety Information for healthcare professionals
Safety Information for healthcare professionals
Intera 3000 Hepatic Artery Infusion Pump Safety Information
Important: Information on this site is not meant as medical advice and should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.
Indications
The pump is indicated for the continuous regional delivery of the following infusates with arterial administration:
The approved labeling for Cerona Therapeutics Floxuridine for Injection, USP stipulates the indications, contraindications, and warnings for use of the drug in the pump.
Bacteriostatic water or saline must be used to achieve the desired concentration of the drug. Heparinized saline can be used during an interruption of Hepatic Artery Infusion therapy to maintain catheter patency.
Glycerin infusion is indicated for patients who are receiving continuous Hepatic Arterial Infusion Chemotherapy. Glycerin infusion is employed as a placebo to keep the catheter patent or to extend the refill interval for patients who require therapy interruption or withdrawal.
The Intera 3000 Hepatic Artery Infusion Pump is indicated for use in the adult population only.
Contraindictions
The Intera 3000 Hepatic Artery Infusion Pump is contraindicated for use in patients with
Contraindications relating to the specific drug to be used must be observed and followed per the approved drug labeling.
Warnings
The pump must be implanted and refilled only by qualified medical personnel, knowledgeable in the surgical use and servicing of implantable devices and catheters, and trained specifically to implant or refill the pump.
Use of the pump by personnel not properly trained in its implantation and/or servicing may lead to serious consequences involving either under or over-delivery of drug to the patient. In the event of an over-delivery of drug refer to the approved drug labeling for appropriate action.
Utilization of the pump requires the proper handling (filling, storage and dispensing) of a significant volume/dosage of drug. This amount of drug can be extremely harmful to the patient if delivered suddenly or inappropriately.
Bolus access and pump refill procedures must be performed using the correct access needle. Never attempt to refill the pump using a special bolus needle. This use will result in giving a bolus injection to the patient and can cause a fatal drug overdose.
Precautions Regarding The Use Of The Pump
Drug extravasation can result if the instructions for use are not followed correctly during a pump refill (see Pump Refill Procedure section) or bolus procedure (see Bolus Procedure).
It is important that a Refill Kit be utilized for pump refill and that the refill procedure be carried out in accordance with the instructions provided in this pamphlet and in the Refill Kit. A special bolus needle must be utilized to successfully perform a bolus procedure.
Adverse Events
Possible adverse events of the pump are those potential risks associated with any implanted drug delivery device and include: catheter thrombosis, bolus path occlusion, vessel thrombosis, pump dislodgement, seroma, or recurrent hematoma, infection, extravasation, catheter shear, dislodgement or leakage, migration, arterial pseudoaneursym, arterial dissection, and extrahepatic perfusion.
Caution:
Federal law (USA) restricts this device to sale by or on the order of a physician.
To read more about Hepatic Artery Infusion (HAI) therapy, please read HAI Patient Stories and visit our Patient and Caregivers Resources page.
HAI Therapy
Clinical Evidence
Intera 3000 HAI Pump
24/7 Clinical Call : USA & Canada (800) 660-2660
WS-1014 Rev A
© Copyright 2023 Intera Oncology.
All Rights Reserved. Designed by WollnerStudios.
HAI Therapy
Clinical Evidence
Intera 3000 HAI Pump
24/7 Clinical Call : USA & Canada (800) 660-2660
WS-1014 Rev A